---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-23-000012"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:36:02.082869+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q4 net loss $320M on $408M legal reserve; provides 2023 outlook of 5-9% growth

## Summary
- Q4 net revenues $252M (+4% YoY); net loss $320M ($1.14/share) vs net income $36M in Q4 2021.
- Q4 net loss includes $408M reserve for ethylene oxide claims settlement in Cook County, IL.
- Q4 adjusted EBITDA $130M (+4% YoY); adjusted EPS $0.25 (+$0.02).
- Closed $500M Term Loan B in February 2023.
- Full-year 2023 outlook: net revenues and adjusted EBITDA growth of 5% to 9%.

## SEC filing metadata
- accession: 0001822479-23-000012
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000012/0001822479-23-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000012/shc-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-23-000012
- JSON: https://secwatch.observer/filing/0001822479-23-000012.json
- Plain text: https://secwatch.observer/filing/0001822479-23-000012.txt

## Key facts
- Earnings Releases
  Sotera Health Co updated its Full-year 2023 guidance (initiated).
  - Period: Full-year 2023
  - Guidance: initiated
  - Result: guidance update
  source text: Full-year 2023 outlook Net Revenues and Adjusted EBITDA growth of 5% to 9%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000012/0001822479-23-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.